ArticleThe American journal of gastroenterology2026
Glucagon-Like Peptide-1 Receptor Agonist Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes in the All of Us Research Program.
Erik Almazan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.